P16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients With Metastatic Colorectal Cancer
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2014.314
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2016
Authors
Publisher
Korean Cancer Association